Engineering nanotheranostic strategies for liver cancer

doi:10.4251/wjgo.v13.i10.1213

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7132)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-11) series.

Item

Count

PDF

453

WORD

143

HTML

3424

Figures (1-11)

317

Sum=4337

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

350

Download

951

Sum=1301

Publishing Process of This Article

Item

Count

Browse

556

Download

938

Sum=1494

Oct 15, 2021 (publication date) through Jul 30, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1213-1228
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1213

Full Size Figure Download Figure

Figure 4 Dual-sensitive nanodrug delivery for treatment of hepatocellular carcinoma. Based on the tumor microenvironment, a copolymer system was designed to rapidly release sorafenib in response to high cytoplasmic glutathione and low pH. Citation: Cai M, Li B, Lin L, Huang J, An Y, Huang W, Zhou Z, Wang Y, Shuai X, Zhu K. A reduction and pH dual-sensitive nanodrug for targeted theranostics in hepatocellular carcinoma. Biomater Sci 2020; 8: 3485-3499. Copyright ^©The Authors 2020. Published by Royal Society of Chemistry.

Citation: Cao L, Zhu YQ, Wu ZX, Wang GX, Cheng HW. Engineering nanotheranostic strategies for liver cancer. World J Gastrointest Oncol 2021; 13(10): 1213-1228
URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1213.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1213